New Nomogram Improves Post-RP Metastasis Predictions
Nomogram based on a cohort of men with high-risk prostate cancer is more accurate than the CAPRA and MSKCC nomograms, researchers report.
Nomogram based on a cohort of men with high-risk prostate cancer is more accurate than the CAPRA and MSKCC nomograms, researchers report.
In a study, 86% of prostatic urethral lift patients experienced symptom relief in the first month.
Differences in the effect of heat on evaporative water loss may help explain the disparity in kidney stone risk between men and women.
A single-center study found that most staghorn stones have a metabolic composition rather than an infectious cause.
Men who present with prostate cancer bone metastasis and no visceral metastases have a median survival time of 37 months, study finds.
Sensitivity is 90% for BLC compared with 75% for white light cystoscopy.
The protective effect of the diabetes drug metformin among patients who undergo surgery for non-muscle invasive bladder cancer is dose dependent, according to a study.
Findings emerged from an analysis of data from 2588 men who participated in the REDUCE trial.
In a study, 2-year survival rates were 14.4% for whites compared with 6.5% for blacks.
Likelihood of stone passage in patients on medical expulsive therapy is based on variables such as stone size and location and white blood cell count.